Safety/Efficacy Study of Bovine Intestinal Alkaline Phosphatase in Patients With Moderate to Severe Ulcerative Colitis

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

November 30, 2006

Study Completion Date

December 31, 2006

Conditions
Ulcerative Colitis
Interventions
DRUG

bovine intestinal alkaline phosphatase (BIAP)

30,000U/24h for 7 consecutive days via a duodenal catheter

Trial Locations (11)

10128

Ospedale Mauriziano, UOA Gastroenterologia, Torino

48100

Ospedale Santa Maria delle Croci, Servizio di Gastroenterologia e Endoscopia Digestiva, Ravenna

60020

Università di Ancona - Nuovo Complesso Didattico, Facoltà di Medicina e Chirurgia, Clinica di Gastroenterologia, Ancona

703 84

Internal Clinic, Vitkovice Hospital Ostrava, Ostrava

775 20

Teaching Hospital Olomouc, Dep. Internal Clinic, Olomouc

120 00

Center of Gastroenterology at General Teaching Hospital, Prague

40 21

Institute of Clinical and Preventive Medicine (IKEM), Clinic of Hepatogastroenterology, Prague

I-40138

University of Bologna, Dept of Internal Medicine and Gastroenterology, Bologna

06055

Ospedale di Marsciano, Ambulatorio Gastroenterologia, Marsciano

00168

Università Cattolica di Roma, Dipartimento di Medicina Interna, Roma

I-00152

Azienda Ospedaliera S. Camillo - Forlanini, Roma

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

CRM Biometrics GmbH

INDUSTRY

collaborator

Sintesi Research Srl

INDUSTRY

collaborator

Vigilex BV

UNKNOWN

lead

AM-Pharma

INDUSTRY